logo
Share SHARE
FONT-SIZE Plus   Neg

Novavax RSV Vaccine Mid-Stage Trial Shows Positive Results

Shares of Novavax Inc.(NVAX) rose over five percent in after-hours trade Tuesday after its mid-stage study of a vaccine for the treatment of respiratory diseases in women of childbearing age met trial goals.

Top-line data from the phase II trial of respiratory syncytial virus (RSV) vaccine candidate in women of childbearing age accomplished the trial's protocol-specified objectives and supports progression to the next stage of advanced clinical testing, the company said in a statement.

Novavax said the the antibodies in vaccinated women can be expected to be naturally transferred to their infants in utero and thereby may confer passive protection at the earliest stage of life when these infants are extremely vulnerable to severe respiratory disease due to the virus.

The mid-stage study enrolled 330 women of childbearing age who received either one or two injections of a single-dose of vaccine or placebo. The trial evaluated the safety and immunogenicity of two doses of vaccine with and without aluminum phosphate as an adjuvant.

Novavax said the vaccine was well-tolerated and the safety profile was similar to that observed in the early-stage clinical trial.

"These results confirm that our RSV vaccine candidate has the potential to induce clinically useful immunity and has raised no safety concerns. The primary immunogenicity measures confirmed that the vaccine is a potent antigen and the aluminum phosphate adjuvant further enhanced the antibody responses," said Gregory Glenn SVP and Chief Medical Officer of Novavax.

NVAX closed Tuesday's trading at $2.35, down $0.02 or 0.84%, on a volume of 1.8 million shares on the Nasdaq. The stock gained $0.13 or 5.53% in after-hours trade.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Federal Aviation Administration said several pilots complained about pointing of strong green laser beams at planes flying over Long Island. The location was around Farmingdale, during 9.30 pm and 10 pm. Searches are on to locate the exact source of the laser beam. The Federal official suspects that the beam came from a hand-held device. Discount retailer Big Lots, Inc. Friday reported an increase in income from continuing operations for the first quarter, from last year. The company also registered a surge in net income particularly as it had carried a loss from discontinued operations last year. Taco Bell, a division of Yum! Brands Inc, is planning to test delivery of food items on college campuses, the Street reported. The move comes at a time the fast food chain seeks to leverage demand for its popular breakfast and dinner items.
comments powered by Disqus
RELATED NEWS
Trade NVAX now with 
Follow RTT